Cluster Headaches are accepted to be because of a blend of ecological and hereditary components. Around 66% of cases keep running in families. Changing hormone levels might likewise assume a part, as headaches influence marginally a bigger number of young men than young ladies before pubescence, yet around a few times a larger number of ladies than men. The danger of headaches more often than not declines amid pregnancy.
There are two main types of cluster headaches: Episodic cluster headaches-These occur one or more times daily for multiple weeks. The headaches then go away and come back months or years later. Chronic cluster headaches-These occur almost daily with headache-free periods lasting less than one month.
Some studies indicate that the headache prevalence is increasing during the last decades in Spain. Variety of medications have been specifically designed to treat cluster headaches. In addition, some drugs commonly used to treat other conditions also may help relieve or prevent cluster headaches.
The FDA is currently reviewing a new migraine drug called Trexima, which combines the migraine drug Imitrex (sumitriptan) and naproxen sodium (a nonsteroidal anti-inflammatory drug) contained in Aleve and other over-the-counter medications. The triptan prevents blood vessels from dilating. This dilating leads to migraine pain; the anti-inflammatory drug prevents release of an inflammation-triggering enzyme, according to product developers.